Novartis AG wrapped up its long-awaited buyout of the remainder of eyecare group Alcon Inc. for $12.9 billion, after sweetening its original offer with cash.
*For more on this story, read the full Reuters article.
Novartis AG wrapped up its long-awaited buyout of the remainder of eyecare group Alcon Inc. for $12.9 billion, after sweetening its original offer with cash.
*For more on this story, read the full Reuters article.
Sign-up for our FREE Daily eNews update to get the latest Orange County news delivered right to your inbox!
One-Year for Only $99